000 03934nam a2200421 c 4500
999 _c117994
_d117994
001 117994
003 ES-MaUEC
005 20230102113838.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 191202s2019 gw a o |||| 0|eng d
020 _a9783030309305
024 7 _a10.1007/978-3-030-30930-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC394.D35
_bN366 2019
245 0 0 _aNanobiotechnology in Neurodegenerative Diseases
_cedited by Mahendra Rai, Alka Yadav.
250 _aFirst edition
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2019
300 _a1 recurso en línea (XII, 398 páginas)
_b51 ilustraciones, 42 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aBiomedical and Life Sciences (Springer-11642)
505 0 _aNeurodegenerative Diseases: The Real Problem and Nanobiotechnological Solutions -- Nanotechnology at the Rescue of Neurodegenerative Diseases: Tools for Early Diagnostic -- The Role of Nanomedicine in treatment for Neurodegenerative disorders -- Nanobiotechnology in Neurodegenerative Diseases -- Application of Mycogenic Nanoparticles against Neurodegenerative diseases -- Nanotechnology-mediated nose to brain drug delivery for neurodegenerative disorders -- Nanobiotechnology in Parkinson's disease -- Selenium nanoparticles as therapeutic agents in Neurodegenerative diseases -- Role of Supermagnetic nanoparticles in Alzheimer,s disease -- Nanomedicines for improved antiretroviral therapy in Neuro-AIDS -- Nanocarrier mediated drug delivery systems for neurodegenerative diseases -- Gold nanoparticles in diagnosis and treatment of Alzheimer's disease -- Nano-Lipidic Carriers as Potential Drug Delivery Vehicles in Alzheimer's Disease -- Curcumin and its nanoformulations as therapeutic for Alzheimer's disease -- Nanopharmaceuticals for the Improved Treatment of Cerebral Stroke.
520 3 _aThis book focuses on neurodegenerative diseases which have become a major threat to human health. Neurodegenerative diseases are age related disorders and have become increasingly prevalent in the elderly population in recent years. Hence, there is an urgent need to study and develop new strategies and alternative methods for the treatment of neurodegenerative diseases. This book showcases the promises that nanobiotechnology brings in research, diagnosis, and treatment of neurodegenerative diseases. It is very beneficial for varied group of readers including nanotechnologists, biotechnologists, pharmacists, medical professionals, bioengineers, biochemists and researchers working in this field. Nanobiotechnology in Neurodegenerative Diseases include various chapters including neurodegeneration and neurodegenerative diseases, nanotechnology for the rescue of neurodegenerative diseases, promising potential of nanomaterials for diagnosis and therapy of neurodegenerative diseases, nanotechnology mediated nose-to-brain drug delivery, and formulation and characterization of intranasal nanoparticles of antiretroviral drugs.
988 _aPrimersemestre_2020_BiomedLife
650 7 _2embne
_9185363
_aCerebro
_xEnfermedades
700 1 _aRai, Mahendra
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_985587
700 1 _aYadav, Alka
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106996
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783030309299
776 0 8 _iPrinted edition:
_z9783030309312
776 0 8 _iPrinted edition:
_z9783030309329
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-30930-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0